XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.3
Statements of Cash Flows - USD ($)
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash flows from operating activities:    
Net loss $ (9,836,670) $ (8,499,974)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 388,777 407,146
Amortization 2,906 19,334
Amortization of right-of-use assets 274,158 249,972
Inventory reserve 4,972 3,800
Loss on disposal of assets 44,538 0
Share-based compensation expense 626,529 158,288
Changes in operating assets and liabilities:    
Accounts receivable (26,086) (98,872)
Inventory (170,917) (138,666)
Other assets 313,154 359,307
Accounts payable 341,119 (49,449)
Accrued expenses 112,728 45,828
Lease liabilities (304,004) (290,104)
Other liabilities (15,770) (30,696)
Net cash used in operating activities (8,244,566) (7,864,086)
Cash flows from investing activities:    
Purchases of property and equipment (99,018) (313,598)
Net cash used in investing activities (99,018) (313,598)
Cash flows from financing activities:    
Proceeds from the issuance of common stock and warrants in April 2023 Financing 3,899,813 0
Equity issuance costs (547,764) 0
Proceeds from exercise of pre-funded warrants 188 0
Proceeds from exercise of common warrants 1,059,975 0
Proceeds from common stock issued through ESPP and exercised options 1,697 16,151
Net proceeds from issuance of common stock in connection with at-the-market offering 3,373 0
Payments of deferred offering costs 0 (232,845)
Repayment of note payable (327,006) (365,926)
Payments under lease obligations (16,193) (17,075)
Net cash provided by (used in) financing activities 4,074,083 (599,695)
Net change in cash and cash equivalents (4,269,501) (8,777,379)
Cash and cash equivalents:    
Beginning of period 12,961,936 24,783,029
End of period 8,692,435 16,005,650
Cash paid for:    
Interest 9,903 9,622
Income taxes 4,550 5,050
Non-cash investing and financing activities:    
Right-of-use asset obtained in exchange for a lease liability 2,496,968 0
Property and equipment costs included in accounts payable 0 23,037
Commissions and deferred offering costs relating to proceeds from issuance of common stock 6,163 0
Prepaid insurance financed with promissory notes $ 283,334 $ 280,577